OpenBilldrug price receipt

NADAC week of 2026-10-14

SIKLOS 100 MG TABLET

FDA nonproprietary name: hydroxyurea

For 30 tablets

Pharmacies pay

$186.95 filed

30 × $6.23183 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$1,006.95 filed

30 × $33.5651 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

5.4× estimated

Medicare paid 5.4× what pharmacies pay.

Part D averages every strength and form sold under “Siklos” / “Hydroxyurea” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$219.99 estimated

$186.95 + $28.04 (15%) + $5.00 fee per fill = $219.99

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

SIKLOS 100 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as hydroxyurea, under the trade name “Siklos”.

FDA gives its dosage form as tablet, film coated and its route as oral.

The labeler, the company named on the label, is Medunik.

FDA’s Established Pharmacologic Class for it is Antimetabolite.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 71770-0105-60.

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $186.95 for 30 tablets (30 × $6.23183 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The NDC

Other strengths, forms and brands

3 other products in the NADAC file share the FDA nonproprietary name hydroxyurea with SIKLOS 100 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
HYDROXYUREA 500 MG CAPSULE
generic · capsule
$0.18364 per EA filed
eff. 2026-09-23
$0.28533 per EA filed
Part D 2024 average
SIKLOS 1,000 MG TABLET
brand · tablet, film coated
$61.99589 per EA filed
eff. 2026-09-23
$33.5651 per EA filed
Part D 2024 average
SIKLOS 100 MG TABLET this page
brand · tablet, film coated
$6.23183 per EA filed
eff. 2026-09-23
$33.5651 per EA filed
Part D 2024 average
XROMI 100 MG/ML SOLUTION
brand · solution
$4.96667 per ML filed
eff. 2026-09-23
We don’t know yet

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

What Medicare paid

Medicare Part D paid $1,006.95 for 30 tablets, at an average of $33.5651 per EA in 2024 (2024-01-01 to 2024-12-31) for “Siklos” and “Hydroxyurea”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 765 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for SIKLOS 100 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Siklos / Hydroxyurea: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on brand name.